Australia TGA ARTG recordNanoBone SBX Putty - Bone matrix implant, synthetic
Australia TGA ARTG Registered Device · My Biologics Pty Ltd · Artoss GmbH · Class III · Started February 28, 2019
Good Name: My Biologics Pty Ltd - NanoBone SBX Putty - Bone matrix implant, synthetic
- Risk Class
- Class III
- Product Type
- Single Device Product
- ARTG Category
- General
- Start Date
- February 28, 2019
- Effective Date
- February 28, 2019
- Name
- Artoss GmbH
- Country
- Germany
- Address
- Fischerweg 421, Rostock, 18069
NanoBone® | SBX putty is a phase-pure non-sintered synthetic biodegradable bone void filler material consisting of NanoBone® | granulate S39 nanocrystalline osteoconductive hydroxyapatite and a water soluble carrier material containing poloxamer, which is embedded in a silica gel matrix of granulate porosity of approx. 80 %. The device is provided sterile either in a standard applicator or in a narrow applicator for quick delivery of the SBX putty (NanoBone® QD), which allows for the treatment of bone defects of smaller and difficult to access areas.
Access comprehensive regulatory information for NanoBone SBX Putty - Bone matrix implant, synthetic in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is sponsored by My Biologics Pty Ltd, manufactured by Artoss GmbH in Germany. The device registration started on February 28, 2019.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.